Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

118 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Infliximab vs. adalimumab in Crohn's disease: results from 327 patients in an Australian and New Zealand observational cohort study.
Doecke JD, Hartnell F, Bampton P, Bell S, Mahy G, Grover Z, Lewindon P, Jones LV, Sewell K, Krishnaprasad K, Prosser R, Marr D, Fischer J, R Thomas G, Tehan JV, Ding NS, Cooke SE, Moss K, Sechi A, De Cruz P, Grafton R, Connor SJ, Lawrance IC, Gearry RB, Andrews JM, Radford-Smith GL; Australian and New Zealand Inflammatory Bowel Disease Consortium. Doecke JD, et al. Among authors: lewindon p. Aliment Pharmacol Ther. 2017 Feb;45(4):542-552. doi: 10.1111/apt.13880. Epub 2016 Dec 19. Aliment Pharmacol Ther. 2017. PMID: 27995633
Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases.
Mitrev N, Vande Casteele N, Seow CH, Andrews JM, Connor SJ, Moore GT, Barclay M, Begun J, Bryant R, Chan W, Corte C, Ghaly S, Lemberg DA, Kariyawasam V, Lewindon P, Martin J, Mountifield R, Radford-Smith G, Slobodian P, Sparrow M, Toong C, van Langenberg D, Ward MG, Leong RW; IBD Sydney Organisation and the Australian Inflammatory Bowel Diseases Consensus Working Group. Mitrev N, et al. Among authors: lewindon p. Aliment Pharmacol Ther. 2017 Dec;46(11-12):1037-1053. doi: 10.1111/apt.14368. Epub 2017 Oct 13. Aliment Pharmacol Ther. 2017. PMID: 29027257 Review.
Genetic susceptibility in IBD: overlap between ulcerative colitis and Crohn's disease.
Doecke JD, Simms LA, Zhao ZZ, Huang N, Hanigan K, Krishnaprasad K, Roberts RL, Andrews JM, Mahy G, Bampton P, Lewindon P, Florin T, Lawrance IC, Gearry RB, Montgomery GW, Radford-Smith GL. Doecke JD, et al. Among authors: lewindon p. Inflamm Bowel Dis. 2013 Feb;19(2):240-5. doi: 10.1097/MIB.0b013e3182810041. Inflamm Bowel Dis. 2013. PMID: 23348120
Perspectives of paediatric and adult gastroenterologists on transfer and transition care of adolescents with inflammatory bowel disease.
Wright EK, Williams J, Andrews JM, Day AS, Gearry RB, Bampton P, Moore D, Lemberg D, Ravikumaran R, Wilson J, Lewindon P, Radford-Smith G, Rosenbaum J, Catto-Smith A, Desmond PV, Connell WR, Cameron D, Alex G, Bell SJ, De Cruz P. Wright EK, et al. Among authors: lewindon p. Intern Med J. 2014 May;44(5):490-6. doi: 10.1111/imj.12402. Intern Med J. 2014. PMID: 24589174
Standardisation of intestinal ultrasound scoring in clinical trials for luminal Crohn's disease.
Goodsall TM, Jairath V, Feagan BG, Parker CE, Nguyen TM, Guizzetti L, Asthana AK, Begun J, Christensen B, Friedman AB, Kucharzik T, Lee A, Lewindon PJ, Maaser C, Novak KL, Rimola J, Taylor KM, Taylor SA, White LS, Wilkens R, Wilson SR, Wright EK, Bryant RV, Ma C. Goodsall TM, et al. Aliment Pharmacol Ther. 2021 Apr;53(8):873-886. doi: 10.1111/apt.16288. Epub 2021 Feb 28. Aliment Pharmacol Ther. 2021. PMID: 33641221
118 results